About CELLnTEC
CELLnTEC is a company based in Bern (Switzerland) founded in 2001 by Eliane Muller and Peter Girling. CELLnTEC offers products and services including Certified Media, Primary Human Cells, and 2D/3D Starter Kits. CELLnTEC operates in a competitive market with competitors including BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and Prolific Machines, among others.
- Headquarter Bern, Switzerland
- Founders Eliane Muller, Peter Girling
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cellntec.com
- Social LinkedIn
- Legal Name Cellntec Advanced Cell Systems
- Investors
Products & Services of CELLnTEC
CELLnTEC offers a comprehensive portfolio of products and services, including Certified Media, Primary Human Cells, and 2D/3D Starter Kits.
Chemically defined media for reproducible 2D and 3D cell models.
Cells for in vivo-like assays in research applications.
Kits with reagents for initiating cell culture systems.
Funding Insights of CELLnTEC
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of CELLnTEC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2001 | – | Seed | – | Venturelab | – |
1 investors in total: 1 institutional.
Investors in CELLnTEC
CELLnTEC has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venturelab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startup acceleration programs are operated across sectors to support growth. | – | venturelab.swiss | Schlieren, Switzerland |
Investor details for CELLnTEC
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CELLnTEC
2 people are tracked at CELLnTEC (2 in leadership).
| Name | Role | Group |
|---|---|---|
Eliane Muller | Co-Founder & Chairman | Leadership |
Peter Girling | Co-Founder | Leadership |
Complete people profiles for CELLnTEC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CELLnTEC
2 dated milestones of CELLnTEC, from founding to its latest funding, stage changes and deals.
- Founded CELLnTEC is founded.
- Funding First funding round.
Competitors of CELLnTEC
CELLnTEC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, RoosterBio, Shanghai Doning Biotechnology, Polyplus Transfection and Prolific Machines, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | – | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | |
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| duoningbio.com | 2005 | Shanghai, China | $14.88M | – | Serum-free cell culture media is supplied to biopharmaceutical industries. | |
| polyplus-transfection.com | 2001 | Illkirch Graffenstaden, France | $3.23M | – | Transfection Solutions for Healthcare and Life Sciences organizations | |
| prolific-machines.com | 2020 | United States | $55M | – | Photomolecular biology platform is provided for controlling cellular functions dynamically. | |
| arunabio.com | 2017 | Athens, United States | $38.51M | – | Neural exosome platform is developed for neurodegenerative disease therapeutics. | |
| biotangents.co.uk | 2015 | Edinburgh, United Kingdom | $5.62M | 13 | Veterinary diagnostics products are developed for bovine viral diarrhea testing. | |
| fabricnano.com | 2018 | London, United Kingdom | $22.6M | 12 | DNA-based flow reactors are developed for biochemical production. | |
| partillion.com | 2020 | Los Angeles, United States | $9.87M | 15 | Single-cell assays are developed for advanced cell analysis using nanovials. | |
| idtdna.com | 1987 | Coralville, United States | – | – | Provider of oligonucleotide-based reagents and kits |
Detailed competitors of CELLnTEC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CELLnTEC
The website of CELLnTEC (cellntec.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▼ 39.1% vs previous month
Websites whose visitors overlap most with CELLnTEC. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| invitria.com | 100% | – | #3,790,077 | View details | |
gembio.com | gembio.com | 99% | – | – | – |
| caltagmedsystems.co.uk | 99% | – | #1,664,753 | View details | |
| cellapplications.com | 98% | 18.2K | #1,601,552 | View details | |
| cellbiolabs.com | 98% | 38.9K | #876,566 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for CELLnTEC
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to CELLnTEC
10 companies that operate in the same segment as CELLnTEC (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CELLnTEC
CELLnTEC was founded in 2001.
CELLnTEC is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.
CELLnTEC was founded in 2001 in Bern, Switzerland, within the biotechnology sector focused on epithelial cell biology. Precision culture media for proliferation, differentiation, co-culture, and aging of various cell types in 2D and 3D formats are developed and offered. The product portfolio includes specialty media and in vitro models tailored to epithelial applications, supporting research in cell-based studies. Operations are centered in Switzerland, serving global scientific communities.
CELLnTEC's top competitors include FabricNano, RoosterBio and Prolific Machines.
CELLnTEC offers Certified Media, Primary Human Cells, and 2D/3D Starter Kits.
CELLnTEC has 1 investor. Key investors include Venturelab.
CELLnTEC operates through Cellntec Advanced Cell Systems.